Orphan Drug designation

Related by string. Orphan Drug Designation * orphaned . Orphans . orphans : Little Orphan Annie . widows orphans . Swedish Orphan Biovitrum / Drugs . DRUG . drugs : Drug Task Force . Prescription Drug User Fee . Drug Enforcement Administration / designations . Designations . Designation : Fast Track designation . enemy combatant designation * Receives Orphan Drug Designation *

Related by context. Frequent words. (Click for all words.) 84 Orphan Drug Designation 83 Orphan Drug status 81 orphan designation 76 orphan drug 74 Orphan Medicinal Product 74 Fast Track Designation 74 orphan medicinal product 70 Fast Track designation 70 Orphan Drug 69 Marketing Authorization 69 granted orphan 67 Priority Review 67 ATryn R 66 Icatibant 66 Mutual Recognition Procedure 65 Torisel 65 methylnaltrexone 65 Loramyc ® 65 Nexavar ® 64 granted Orphan Drug 64 Marketing Authorization Application 64 Abstral 64 oncology indications 63 Pivotal Phase III 63 Jevtana 63 davunetide 62 TREANDA 62 taliglucerase alfa 62 Avastin bevacizumab 62 Everolimus 62 Nimotuzumab 62 tamibarotene 61 BENLYSTA 61 silodosin 61 Marketing Authorization Application MAA 61 clofarabine 61 European Medicines Evaluation 61 TORISEL 61 eltrombopag 61 Promacta 61 Apricus Bio 61 Biologics License Application 61 PROMACTA 61 relapsing forms 61 Cladribine Tablets 61 Investigational Device Exemption 60 Irinotecan 60 Onsolis 60 FDA Clearance 60 KNS # 60 Satraplatin 60 HIV protease inhibitor 60 Azedra 60 Cethrin 60 Relistor 60 ELAPRASE 60 NOXAFIL 60 Advexin 60 VPRIV 60 alvimopan 59 Lenalidomide 59 Qualifying Therapeutic Discovery 59 Alemtuzumab 59 BEMA Fentanyl 59 injectable formulation 59 Drug Candidate 59 thymalfasin 59 Ilaris 59 prGCD 59 Ceplene 59 pseudobulbar affect PBA 59 DAVANAT ® 59 Maraviroc 59 Pixantrone 59 Sancuso 59 Phenoptin 59 SFDA approval 59 Zelrix 59 diabetic neuropathic pain 59 ONSOLIS 59 Bronchitol 59 Allovectin 7 R 59 Increlex 59 pediatric exclusivity 59 Vasovist 59 Rifaximin 58 Ceplene R 58 GEM #S 58 sBLA 58 received CE Marking 58 Pivotal Trial 58 Vilazodone 58 ADVEXIN 58 Kuvan 58 Esbriet 58 Pivotal Phase 58 Swissmedic 58 XGEVA 58 Bevacizumab 58 FOSRENOL 58 CE Marking

Back to home page